These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9039933

  • 1. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection.
    Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP.
    Transplantation; 1997 Feb 15; 63(3):414-20. PubMed ID: 9039933
    [Abstract] [Full Text] [Related]

  • 2. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment.
    Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F, Schena FP.
    J Am Soc Nephrol; 1996 Jun 15; 7(6):906-13. PubMed ID: 8793800
    [Abstract] [Full Text] [Related]

  • 3. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun 15; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 4. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul 15; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 5. [The role of monocyte chemotactic peptide (MCP-1) in chronic renal allograft rejection].
    Boratyńska M.
    Pol Arch Med Wewn; 1998 Apr 15; 99(4):272-80. PubMed ID: 9760814
    [Abstract] [Full Text] [Related]

  • 6. [Significance of detecting urinary monocyte chemotactic peptide-1 in renal transplant recipient].
    Sun XH, Tan JM, Wu WZ, Lin WH, Li QS, Fang YH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov 15; 19(6):563-4. PubMed ID: 15182651
    [Abstract] [Full Text] [Related]

  • 7. Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)--sensitive rejection markers in renal graft recipients.
    Dubiński B, Boratyńska M, Kopeć W, Szyber P, Patrzałek D, Klinger M.
    Transpl Immunol; 2008 Jan 15; 18(3):203-7. PubMed ID: 18047927
    [Abstract] [Full Text] [Related]

  • 8. Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1.
    Gesualdo L, Grandaliano G, Ranieri E, Monno R, Montinaro V, Manno C, Schena FP.
    Kidney Int; 1997 Jan 15; 51(1):155-63. PubMed ID: 8995729
    [Abstract] [Full Text] [Related]

  • 9. Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection.
    Sibbring JS, Sharma A, McDicken IW, Sells RA, Christmas SE.
    Transpl Immunol; 1998 Dec 15; 6(4):203-8. PubMed ID: 10342733
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
    Rüster M, Sperschneider H, Fünfstück R, Stein G, Gröne HJ.
    Clin Nephrol; 2004 Jan 15; 61(1):30-9. PubMed ID: 14964455
    [Abstract] [Full Text] [Related]

  • 11. A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation.
    Krüger B, Schröppel B, Ashkan R, Marder B, Zülke C, Murphy B, Krämer BK, Fischereder M.
    J Am Soc Nephrol; 2002 Oct 15; 13(10):2585-9. PubMed ID: 12239249
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of interleukin-8, interleukin-10, monocyte chemotactic protein-1, and monocyte chemotactic protein-3 in peripheral blood monocytes in stable lung transplant recipients: are immunosuppression regimens working?
    Hodge G, Hodge S, Reynolds PN, Holmes M.
    Transplantation; 2005 Feb 27; 79(4):387-91. PubMed ID: 15729163
    [Abstract] [Full Text] [Related]

  • 13. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Levels and Its Association with Renal Allograft Rejection.
    Raza A, Firasat S, Khaliq S, Khan AR, Mahmood S, Aziz T, Mubarak M, Naqvi SA, Rizvi SA, Abid A.
    Immunol Invest; 2017 Apr 27; 46(3):251-262. PubMed ID: 27960564
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy.
    Chertin B, Farkas A, Puri P.
    Eur Urol; 2003 Jul 27; 44(1):144-9. PubMed ID: 12814691
    [Abstract] [Full Text] [Related]

  • 15. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection.
    Le Meur Y, Jose MD, Mu W, Atkins RC, Chadban SJ.
    Transplantation; 2002 Apr 27; 73(8):1318-24. PubMed ID: 11981428
    [Abstract] [Full Text] [Related]

  • 16. Immunocytological urinalysis and monocyte chemotactic peptide-1 in renal transplant recipients with polyomavirus replication.
    Boratyńska M, Dubiński B, Rybka K, Jezior D, Szyber P, Klinger M.
    Transplant Proc; 2006 Apr 27; 38(1):151-4. PubMed ID: 16504689
    [Abstract] [Full Text] [Related]

  • 17. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation.
    Chakravorty SJ, Howie AJ, Girdlestone J, Gentle D, Savage CO.
    J Pathol; 2001 Jun 27; 194(2):239-46. PubMed ID: 11400154
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.
    Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda SI, Takasawa K, Yoshimura M, Kida H, Kobayashi KI, Mukaida N, Naito T, Matsushima K, Yokoyama H.
    Kidney Int; 2000 Oct 27; 58(4):1492-9. PubMed ID: 11012884
    [Abstract] [Full Text] [Related]

  • 19. Antibody-mediated rejection with a striking interstitial monocyte/macrophage infiltration in a renal allograft under FTY720 treatment.
    Sis B, Grynoch R, Murray AG, Campbell P, Solez K.
    Am J Kidney Dis; 2008 Jan 27; 51(1):127-30. PubMed ID: 18155542
    [Abstract] [Full Text] [Related]

  • 20. Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.
    Alpay N, Ozkok A, Caliskan Y, Akagun T, Cinar SA, Deniz G, Sariyar M, Yildiz A.
    Clin Exp Nephrol; 2014 Dec 27; 18(6):961-7. PubMed ID: 24515306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.